Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02302-4

CardioFocus vs. Contact Force guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation (CF2)
A. Metzner1, C.-H. Heeger2, D. Q. Nguyen3, T. Brodherr4, D. Nguyen5, M. B. Arnold6, N. C. Ewertsen7, R. R. Tilz2, B. Reißmann8, A. Rillig1
1Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herz- und Gefäßzentrum Hamburg, Hamburg; 2Klinik für Rhythmologie, Universitätsklinikum Schleswig-Holstein, Lübeck; 3Innere Medizin III - Kardiologie, St. Vinzenz-Hospital, Köln; 4Kardiologie, Krankenhaus Agatharied, Hausham; 5Facharztzentrum Düsseldorf, Düsseldorf; 6Klinik für Kardiologie, Pneumologie und internistische Intensivmedizin, Klinikum Passau, Passau; 7Klinik für Innere Medizin, Kardiologie und konservative Intensivmedizin, Vivantes Klinikum Am Urban, Berlin; 8Allgemeine und Interventionelle Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg, Hamburg;

Background:

So far, no head-to-head comparison of endoscopic laserballoon-guided to contact-force radio frequency (RF)-based pulmonary vein isolation (PV) was performed in a prospective, randomized, multicenter study.

Objectives:

To assess safety and efficacy of laserballoon-guided versus contact-force radio frequency (RF)-based PVI.

Methods:

A multi-center study (1:1) to compare acute and 12-months clinical outcomes of patients with paroxysmal AF (PAF) undergoing ablation using the laserballoon catheter or a Contact Force Sensing Irrigated RF (CF RF) ablation catheter. At 3, 6 and 12 months post ablation 72 hours Holter ECGs were performed.

Results:

362 patients were randomized to CF RF- (n=179) and to laserballoon-guided PVI (n=183). PVI was achieved in 99.4% PVs in the CF RF and in 96.5% in the laserballoon group (p=0.064) with no difference in procedure time. Fluoroscopy time was significantly shorter, dose area product significantly lower in the CF RF group. In the CF RF group 100/179 (61%) patients had all scheduled Holter ECG visits and 97/183 (53%) patients in the laserballoon arm with a total of 50 (27%) and 52 (27%) patients lost to follow-up. After 12 months a total of 106/129 (82.2%) and 110/131 (84%) patients were in stable SR in the CF RF arm and in the laserballoon arm (p=0.699). 11 (6.1%) and 15 (8.2%) major complications occurred in the CF RF and in the laserballoon group.

Conclusions:

Application of both technologies results in high and comparable rates of acute PVI and in comparable efficacy in prevention of AF recurrences.


https://dgk.org/kongress_programme/ht2023/aP569.html